A Clinico-Pathological and Prognostic Analysis of Non-Hodgkin Lymphoma: A study of 203 patients
Open Access
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 27 (5) , 489-495
- https://doi.org/10.3109/02841868809093576
Abstract
In a retrospective analysis of 203 patients with non-Hodgkin lymphoma (NHL) treated between 1975 and 1985, the relationship between pathology, clinical presentation and course, was studied, using the Kiel classification. This classification was a much better predictor of prognosis than clinical stage and within the different pathology groups there was no significant difference between the stages concerning the survival rate. In the group with low grade malignancy this latter was positively associated with nodular architecture, bone marrow involvement and complete or partial response to therapy. In the high grade group, the survival was positively correlated to complete remission, but no plateau was seen in the survival curve. All extranodal sites had poor survival. For both grades, age (>60 years), systemic symptoms and biologic signs (Ann Arbor ‘B’ and ‘b’) were unfavorable prognostic factors.Keywords
This publication has 29 references indexed in Scilit:
- Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study GroupHematological Oncology, 1984
- Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic typeThe American Journal of Medicine, 1983
- Report on the EORTC lymphoma trial 20751International Journal of Radiation Oncology*Biology*Physics, 1983
- Malignant lymphoma I. The histology and staging of 473 patients at the national cancer instituteCancer, 1982
- Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the national cancer instituteCancer, 1982
- An approach to classifying prognostic factors related to survival experience for non-Hodgkin's lymphoma patients: Based on a series of 982 patients: 1967–1975Cancer, 1981
- Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1978
- Factors Predicting for Response and Survival in Adults With Advanced Non-Hodgkin's LymphomaArchives of internal medicine (1960), 1978
- CLASSIFICATION OF NON-HODGKIN'S LYMPHOMASThe Lancet, 1974
- Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomasCancer, 1974